Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.

Xu, X-L; Yao, Y-L; Xu, W-Z; Feng, J-G; Mao, W-M

Xu, X-L; Yao, Y-L; Xu, W-Z; Feng, J-G; Mao, W-M.

Affiliation

Xu XL; Key Laboratory on Diagnosis and Treatment Technology for Thoracic Cancer, Zhejiang Cancer Hospital (Zhejiang Cancer Research Institute).
Yao YL; Key Laboratory on Diagnosis and Treatment Technology for Thoracic Cancer, Zhejiang Cancer Hospital (Zhejiang Cancer Research Institute).
Xu WZ; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou City, China.
Feng JG; Key Laboratory on Diagnosis and Treatment Technology for Thoracic Cancer, Zhejiang Cancer Hospital (Zhejiang Cancer Research Institute).
Mao WM; Key Laboratory on Diagnosis and Treatment Technology for Thoracic Cancer, Zhejiang Cancer Hospital (Zhejiang Cancer Research Institute), maowm1318@163.com.

Genet Mol Res ; 14(2): 3525-33, 2015 Apr 15.

Article de En | MEDLINE | ID: mdl-25966119

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Carcinome pulmonaire non à petites cellules / Polymorphisme de nucléotide simple / Protéines de liaison à l'ADN / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Genet Mol Res Sujet du journal: BIOLOGIA MOLECULAR / GENETICA Année: 2015 Type de document: Article Pays de publication: Brésil

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google